WHAT IS TOLBUTAMIDE TOLERANCE TEST (TTT)?

WHAT IS TOLBUTAMIDE TOLERANCE TEST (TTT)?

There are primarily three types of hypoglycemia: one type that involves an insulin-secreting tumour of the pancreas known as “insulinoma;” one that that is the result of hyperactive islet cells; and a third type that is a result of liver disease. Insulinomas secrete disproportionately high levels of insulin in response to blood glucose levels, causing frequent hypoglycemic episodes. Insulinoma can be diagnosed through this indirect test that administers intravenous tolbutamide, a sulfonylurea that stimulates the pancreas to produce insulin. When administered to a person with insulinoma, there is an exaggerated response, causing abnormally rapid and high insulin levels and abnormally prolonged hypoglycemic response. 

(Visited 8 times, 1 visits today)
KNOWLEDGE BASE
About Genomic Medicine UK

Genomic Medicine UK is the home of comprehensive genomic testing in London. Our consultant medical doctors work tirelessly to provide the highest standards of medical laboratory testing for personalised medical treatments, genomic risk assessments for common diseases and genomic risk assessment for cancers at an affordable cost for everybody. We use state-of-the-art modern technologies of next-generation sequencing and DNA chip microarray to provide all of our patients and partner doctors with a reliable, evidence-based, thorough and valuable medical service.

X